Document Detail

The live-birth prevalence of mucopolysaccharidoses in Estonia.
MedLine Citation:
PMID:  22480138     Owner:  NLM     Status:  MEDLINE    
Previous studies on the prevalence of mucopolysaccharidoses (MPS) in different populations have shown considerable variations. There are, however, few data with regard to the prevalence of MPSs in Fenno-Ugric populations or in north-eastern Europe, except for a report about Scandinavian countries. A retrospective epidemiological study of MPSs in Estonia was undertaken, and live-birth prevalence of MPS patients born between 1985 and 2006 was estimated. The live-birth prevalence for all MPS subtypes was found to be 4.05 per 100,000 live births, which is consistent with most other European studies. MPS II had the highest calculated incidence, with 2.16 per 100,000 live births (4.2 per 100,000 male live births), forming 53% of all diagnosed MPS cases, and was twice as high as in other studied European populations. The second most common subtype was MPS IIIA, with a live-birth prevalence of 1.62 in 100,000 live births. With 0.27 out of 100,000 live births, MPS VI had the third-highest live-birth prevalence. No cases of MPS I were diagnosed in Estonia, making the prevalence of MPS I in Estonia much lower than in other European populations. MPSs are the third most frequent inborn error of metabolism in Estonia after phenylketonuria and galactosemia.
Külliki Krabbi; Kairit Joost; Riina Zordania; Inga Talvik; Reet Rein; Jan G M Huijmans; Frans V Verheijen; Katrin Õunap
Related Documents :
2656138 - Reproducible lactulose hydrogen breath test as a measure of mouth-to-cecum transit time.
11501368 - The bioenterics intragastric balloon (bib): how to use it.
7115048 - Reducing back displacement in the powered reclining wheelchair.
18205068 - Incorporation of zebularine from its 2'-deoxyribonucleoside triphosphate derivative and...
15018038 - God, faith, and death: the impact of biological and religious correlates on mortality.
24570828 - Evaluation of serum interleukins-6, 8 and 10 levels as diagnostic markers of neonatal i...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-04-05
Journal Detail:
Title:  Genetic testing and molecular biomarkers     Volume:  16     ISSN:  1945-0257     ISO Abbreviation:  Genet Test Mol Biomarkers     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-08-29     Completed Date:  2013-01-14     Revised Date:  2013-08-14    
Medline Journal Info:
Nlm Unique ID:  101494210     Medline TA:  Genet Test Mol Biomarkers     Country:  United States    
Other Details:
Languages:  eng     Pagination:  846-9     Citation Subset:  IM    
Institute of Chemistry, Faculty of Sciences, Tallinn University of Technology, Tallinn, Estonia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Estonia / epidemiology
Mucopolysaccharidoses / classification,  epidemiology*
Retrospective Studies

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  In vivo wound-healing efficacy and antioxidant activity of Achyranthes aspera in experimental burns.
Next Document:  Prevalence of the NKG2D Thr72Ala polymorphism in patients with cervical carcinoma.